GEVA Insider Trading Activity and SEC Form 4 Filings
GEVA insider trading summary
No open-market insider purchases or sales of Synageva Biopharma Corp (GEVA) have been reported on SEC Form 4 in the past 12 months.
Latest GEVA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 8, 2015 | Glen Williams | SVP, Technical Operations | Sell | $544K (2,520 @ $215.72) |
| Jun 8, 2015 | Glen Williams | SVP, Technical Operations | Sell | $2.2M (10,396 @ $214.72) |
| May 6, 2015 | Glen Williams | SVP, Technical Operations | Sell | $136K (666 @ $203.99) |
| May 6, 2015 | Glen Williams | SVP, Technical Operations | Sell | $22K (100 @ $215.26) |
| May 6, 2015 | Glen Williams | SVP, Technical Operations | Sell | $83K (400 @ $206.27) |
| May 6, 2015 | Glen Williams | SVP, Technical Operations | Sell | $82K (400 @ $204.94) |
| May 6, 2015 | Glen Williams | SVP, Technical Operations | Sell | $21K (100 @ $206.97) |
| Apr 27, 2015 | Anthony Quinn | EVP, CMO & Head of R&D | Sell | $1.1M (10,000 @ $110.00) |
| Apr 21, 2015 | Anthony Quinn | EVP, CMO & Head of R&D | Sell | $1.1M (10,000 @ $108.00) |
| Apr 15, 2015 | Anthony Quinn | EVP, CMO & Head of R&D | Sell | $1.1M (10,000 @ $105.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.